These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32349553)

  • 1. The gut-brain axis and gut inflammation in Parkinson's disease: stopping neurodegeneration at the toll gate.
    Gorecki AM; Dunlop SA; Rodger J; Anderton RS
    Expert Opin Ther Targets; 2020 Jul; 24(7):601-604. PubMed ID: 32349553
    [No Abstract]   [Full Text] [Related]  

  • 2. Can the gut be the missing piece in uncovering PD pathogenesis?
    Chapelet G; Leclair-Visonneau L; Clairembault T; Neunlist M; Derkinderen P
    Parkinsonism Relat Disord; 2019 Feb; 59():26-31. PubMed ID: 30448099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota, 1013 new pieces in the Parkinson's disease puzzle.
    Scheperjans F
    Curr Opin Neurol; 2016 Dec; 29(6):773-780. PubMed ID: 27653288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gut and Nonmotor Symptoms in Parkinson's Disease.
    Klingelhoefer L; Reichmann H
    Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease: Are gut microbes involved?
    Bhattarai Y; Kashyap PC
    Am J Physiol Gastrointest Liver Physiol; 2020 Nov; 319(5):G529-G540. PubMed ID: 32877215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuroscience perspective of the gut theory of Parkinson's disease.
    Smith LM; Parr-Brownlie LC
    Eur J Neurosci; 2019 Mar; 49(6):817-823. PubMed ID: 29446158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice.
    Perez-Pardo P; Dodiya HB; Engen PA; Forsyth CB; Huschens AM; Shaikh M; Voigt RM; Naqib A; Green SJ; Kordower JH; Shannon KM; Garssen J; Kraneveld AD; Keshavarzian A
    Gut; 2019 May; 68(5):829-843. PubMed ID: 30554160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases.
    Herrera AJ; Espinosa-Oliva AM; Oliva-Martin MJ; Carrillo-Jimenez A; Venero JL; de Pablos RM
    Curr Top Med Chem; 2015; 15(21):2193-210. PubMed ID: 26059357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional habits, risk, and progression of Parkinson disease.
    Erro R; Brigo F; Tamburin S; Zamboni M; Antonini A; Tinazzi M
    J Neurol; 2018 Jan; 265(1):12-23. PubMed ID: 29018983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease and Parkinson's disease: common pathophysiological links.
    Lee HS; Lobbestael E; Vermeire S; Sabino J; Cleynen I
    Gut; 2021 Feb; 70(2):408-417. PubMed ID: 33067333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson's disease.
    Ghaisas S; Langley MR; Palanisamy BN; Dutta S; Narayanaswamy K; Plummer PJ; Sarkar S; Ay M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Neurotoxicology; 2019 Dec; 75():186-199. PubMed ID: 31505196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the gut microbiome to combat neurodegeneration.
    Sasmita AO
    Rev Neurosci; 2019 Nov; 30(8):795-805. PubMed ID: 31095511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microbiome-gut-brain axis in acute and chronic brain diseases.
    Benakis C; Martin-Gallausiaux C; Trezzi JP; Melton P; Liesz A; Wilmes P
    Curr Opin Neurobiol; 2020 Apr; 61():1-9. PubMed ID: 31812830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GI infections are associated with an increased risk of Parkinson's disease.
    Nerius M; Doblhammer G; Tamgüney G
    Gut; 2020 Jun; 69(6):1154-1156. PubMed ID: 31201287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.